Huonslab Co., Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase I Study to Evaluate the Safety and Drug Allergy of HLB3-002 in Healthy Volunteers (NCT06713317) | Huonslab Co., Ltd. | 2024-12-02 |
Track Huonslab Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.